Literature DB >> 15546903

CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis.

Ram P Gupta1, You Ai He, Kennerly S Patrick, James R Halpert, Norman H Bell.   

Abstract

Studies were performed to identify the microsomal enzyme that 24-hydroxylates vitamin D, whether 25-hydroxylation occurs, and structure function of the enzyme. Sixteen hepatic recombinant microsomal cytochrome P450 enzymes expressed in baculovirus-infected insect cells were screened for 24-hydroxylase activity. CYP3A4, a vitamin D-25-hydroxylase, and CYP1A1 had the highest 24-hydroxylase activity with 1 alpha-hydroxyvitamin D(2) (1 alpha OHD(2)) as substrate. The ratio of rates of 24-hydroxylation of 1 alpha-hydroxyvitamin D(3) (1 alpha OHD(3)), 1 alpha OHD(2), and vitamin D(2) by CYP3A4 was 3.6/2.8/1.0. Structures of 24-hydroxyvitamin D(2), 1,24(S)-dihydroxyvitamin D(2), and 1,24-dihydroxyvitamin D(3) were confirmed by HPLC and gas chromatography retention time and mass spectroscopy. In characterized human liver microsomes, 24-hydroxylation of 1 alpha OHD(2) by CYP3A4 correlated significantly with 6 beta-hydroxylation of testosterone, a marker of CYP3A4 activity. 24-Hydroxylase activity in recombinant CYP3A4 and pooled human liver microsomes showed dose-dependent inhibition by ketoconazole, troleandomycin, alpha-naphthoflavone, and isoniazid, known inhibitors of CYP3A4. Rates of 24- and 25-hydroxylation of 1 alpha OHD(2) and 1 alpha OHD(3) were determined in recombinant wild-type CYP3A4 and site-directed mutants and naturally occurring variants expressed in Escherichia coli. Substitution of residues showed the most prominent alterations of function at residues 119, 120, 301, 305, and 479. Thus, CYP3A4 is both a 24- and 25-hydroxylase for vitamin D(2), 1 alpha OHD(2), and 1 alpha OHD(3).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546903     DOI: 10.1210/jc.2004-0966

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.

Authors:  N Binkley; D Gemar; J Engelke; R Gangnon; R Ramamurthy; D Krueger; M K Drezner
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

2.  Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

Authors:  Andrew J Annalora; Ekaterina Bobrovnikov-Marjon; Rita Serda; Andrzej Pastuszyn; Sandra E Graham; Craig B Marcus; John L Omdahl
Journal:  Arch Biochem Biophys       Date:  2006-12-03       Impact factor: 4.013

3.  Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterol.

Authors:  Ulf Diczfalusy; Ingemar Björkhem
Journal:  J Lipid Res       Date:  2011-06-07       Impact factor: 5.922

Review 4.  Cytochrome P450-mediated metabolism of vitamin D.

Authors:  Glenville Jones; David E Prosser; Martin Kaufmann
Journal:  J Lipid Res       Date:  2013-04-06       Impact factor: 5.922

5.  CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo.

Authors:  Jinge G Zhu; Justin T Ochalek; Martin Kaufmann; Glenville Jones; Hector F Deluca
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-09       Impact factor: 11.205

6.  DNA methylation-related vitamin D receptor insensitivity in breast cancer.

Authors:  Radharani Marik; Maryjo Fackler; Edward Gabrielson; Martha A Zeiger; Saraswati Sukumar; Vered Stearns; Christopher B Umbricht
Journal:  Cancer Biol Ther       Date:  2010-07-09       Impact factor: 4.742

7.  An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway.

Authors:  Zhican Wang; Yvonne S Lin; Xi Emily Zheng; Tauri Senn; Takanori Hashizume; Michele Scian; Leslie J Dickmann; Sidney D Nelson; Thomas A Baillie; Mary F Hebert; David Blough; Connie L Davis; Kenneth E Thummel
Journal:  Mol Pharmacol       Date:  2011-12-28       Impact factor: 4.436

8.  Hydroxylation of 20-hydroxyvitamin D3 by human CYP3A4.

Authors:  Chloe Y S Cheng; Andrzej T Slominski; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2016-03-09       Impact factor: 4.292

9.  Vitamin d levels and lipid response to atorvastatin.

Authors:  José Luis Pérez-Castrillón; Laura Abad Manteca; Gemma Vega; Javier Del Pino Montes; Daniel de Luis; Antonio Duenas Laita
Journal:  Int J Endocrinol       Date:  2009-08-19       Impact factor: 3.257

10.  Is vitamin D deficiency involved in the immune reconstitution inflammatory syndrome?

Authors:  Anali Conesa-Botella; Chantal Mathieu; Robert Colebunders; Rodrigo Moreno-Reyes; Evelyne van Etten; Lut Lynen; Luc Kestens
Journal:  AIDS Res Ther       Date:  2009-04-21       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.